• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill . Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025

tetano

Editor, Senior Moderator
Euro Surveill


. 2026 May;31(20).
doi: 10.2807/1560-7917.ES.2026.31.20.2600375.
Cross-reactive human antibody responses to H9N2 influenza virus, New York, United States, 2025

Gagandeep Singh[SUP] 1 2 [/SUP], Disha Bhavsar[SUP] 1 2 [/SUP], Lucas M Ferreri[SUP] 3 [/SUP], Jessica R Nardulli[SUP] 1 2 [/SUP], Charles Gleason[SUP] 1 2 [/SUP], Neko Lyttle[SUP] 1 2 [/SUP], Yuexing Chen[SUP] 1 2 [/SUP], Anice C Lowen[SUP] 3 [/SUP], Viviana Simon[SUP] 4 2 5 1 6 [/SUP], Florian Krammer[SUP] 7 8 1 2 5 [/SUP]


Affiliations
Abstract

Understanding population immunity to emerging viruses is critical for risk assessment. We characterised antibody responses to avian influenza A(H9N2) viruses in 298 human sera from adults in New York City. We observed widespread cross-reactive H9-binding antibodies, albeit at lower levels (GMT = 371.3) than against seasonal H3 (GMT = 1,398.0), with low to undetectable haemagglutination inhibition and neutralising antibodies. In contrast, NA-binding and neuraminidase inhibition responses were moderate (GMT = 149.5 and 34.2) and comparable to those against human seasonal N2 (GMT = 259.0 and 42.2).

Keywords: H9N2; avian influenza; influenza A virus; zoonoses.

 
Back
Top